In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

Objective To discuss the risk of recurrence in patients with differentiated thyroid cancer and
emphasize the importance of risk-group stratification. Methods Common risk factors …

Background: The management of thyroid papillary microcarcinoma (PMC) is controversial.
Total thyroidectomy, thyroid lobectomy/isthmectomy, and even no treatment have been …

Criteria overlap for separating between malignant follicular epithelial cell-derived thyroid
gland neoplasms with high grade features of increased mitoses and tumor necrosis but …

Background Many patients with papillary thyroid cancer (PTC) demonstrate satisfactory
outcomes. However, 8%–28% of patients with PTC show tumor recurrence, which may affect …

BACKGROUND: Extrathyroidal extension (ETE) is a risk factor for recurrence of papillary
thyroid carcinoma (PTC). Although initial data supporting this was based on gross ETE …

Background Tumor, node, and metastasis staging in thyroid carcinoma is important for
assessing prognosis. However, patients with stage III or IV disease have an overall survival …

The incidence of thyroid cancer remains high worldwide, and papillary thyroid cancer (PTC)
is the most common type. Potassium Calcium-Activated Channel Subfamily N Member 4 …

Objective: The objective of this study was to determine the incidence and significance of
Delphian node (DN) metastasis in papillary thyroid cancer. Summary of Background Data …

Hypothesis A change in tumor expression profile will be observed during the transformation
of differentiated into anaplastic thyroid carcinoma. Design Cohort study. Setting Population …